Catalyst Investments — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Healing chronic wounds with omega-3 nutrition
HealthtechSarasota, US
Joel Morganroth(Director)Thomas Gardner(Executive Officer, Director)AG Lafley(Director)Ronald Gelbman(Director)Robert Essner(Director)
Co-investorsAstanor Ventures
Omeza is an ocean biotechnology company developing marine-based regenerative wound-care products, including its FDA-cleared OCM wound matrix made from cold-water fish peptides, omega fatty acids, and plant-derived lipids, to treat chronic, hard-to-heal wounds such as diabetic foot ulcers and venous leg ulcers in adults.
BiotechHealthtechMedical DevicesSarasota, US
Cynthia Flowers(Executive Officer, Director)inRonald Gelbman(Director)Thomas Gardner(Executive Officer, Director)Joel Morganroth(Director)Robert Essner(Director)
BoardAG Lafley(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.